The matrix 1 protein of influenza A virus inhibits the transcriptase activity of a model influenza reporter genome in Vivo

Virology

Volumn 249, Issue 1, 1998, Pages 52-61

  Perez, Daniel R ^a   Donis, Ruben O ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; MATRIX PROTEIN; MESSENGER RNA; MUTANT PROTEIN; RIBONUCLEASE; RIBONUCLEOPROTEIN; TRANSCRIPTASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; INFLUENZA VIRUS A; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; VIRUS GENOME; VIRUS TRANSCRIPTION;

ANIMALIA; INFLUENZA A VIRUS; INFLUENZA VIRUS; INFLUENZAVIRUS A; RNA VIRUSES;

EID: 0032530138     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9318     Document Type: Article

References (42)

1. Altschuler M., Tritz R., Hampel A. A method for generating transcripts with defined 5′ and 3′ termini by autolytic processing. Gene. 122:1992;85-90.
2. Ausubel, F. M. Brent, R. Kingston, R. E. Moore, D. D. Seidman, J. G. Smith, J. A. Struhl, K. 1989, Current Protocols in Molecular Biology, Greene Publishing Associates and Wiley-Interscience, New York.
3. Bui M., Whittaker G., Helenius A. Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J. Virol. 70:1996;8391-8401.
4. Bukrinskaya A. G., Vorkunova G. K., Vorkunova N. K. Cytoplasmic and nuclear input virus RNPs in influenza virus-infected cells. J. Gen. Virol. 45:1979;557-567.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
6. Elster C., Fourest E., Baudin F., Larsen K., Cusack S., Ruigrok R. W. A small percentage of influenza virus M1 protein contains zinc but zinc does not influence in vitro M1-RNA interaction. J. Gen. Virol. 75:1994;37-42.
7. Elster C., Larsen K., Gagnon J., Ruigrok R. W. H., Baudin F. Influenza virus M1 protein binds to RNA trough its nuclear localization signal. J. Gen. Virol. 78:1997;1589-1596.
8. Ford C. F., Suominen I., Glatz C. E. Fusion tails for the recovery and purification of recombinant proteins. Prot. Expr. Purif. 2:1991;95-107.
9. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
10. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
11. Hankins R., Nagata K., Kato A., Ishihama A. Mechanism of influenza virus transcription inhibition by matrix (M1) protein. Res. Virol. 141:1990;305-314.
12. Helenius A. Unpacking the incoming influenza virus. Cell. 69:1992;577-578.
13. Herz C., Stavnezer E., Krug R., Gurney T. Jr. Influenza virus, an RNA virus, synthesizes its messenger RNA in the nucleus of infected cells. Cell. 26:1981;391-400.
14. Huang T. S., Palese P., Krystal M. Determination of influenza virus proteins required for genome replication. J. Virol. 64:1990;5669-5673.
15. Hudson J. B., Flawith J., Dimmock N. J. Early events in influenza virus infection. III. The formation of a nucleoplasmic ribonucleoprotein complex from the input virion. Virology. 86:1978;167-176.
16. Inglis S. C., Carroll A. R., Lamb R. A., Mahy B. W. Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology. 74:1976;489-503.
17. Kretzschmar E., Bui M., Rose J. Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Virology. 220:1996;37-45.
18. Krug, R. 1989, Expression and replication of the influenza virus genome, In, The Influenza Viruses, 89, 152, Plenum Press, New York.
19. Lamb, R. A. 1989, Genes and proteins of the influenza viruses, In, The Influenza Viruses, R. M. Krug, 1, 88, Plenum Press, New York.
20. Luytjes W., Krystal M., Enami M., Pavin J. D., Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell. 59:1989;1107-1113.
21. Mahy, B. 1983, Mutants of influenza virus, In, Genetics of Influenza Viruses, Palese, P.Kingsbury, D. 192, 254, Springer-Verlag, Wien, New York.
22. Malone R. W., Felgner P. L., Verma I. M. Cationic liposome-mediated RNA transfection. Proc. Natl. Acad. Sci. USA. 86:1989;6077-6081.
23. Martin K., Helenius A. Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import. Cell. 67:1991a;117-130.
24. Martin K., Helenius A. Transport of incoming influenza virus nucleocapsids into the nucleus. J. Virol. 65:1991b;232-244.
25. Mena I., de la Luna S., Albo C., Martin J., Nieto A., Ortin J., Portela A. Synthesis of biologically active influenza virus core proteins using a vaccinia virus-T7 RNA polymerase expression system. J. Gen. Virol. 75:1994;2109-2114.
26. Novak J. E., Kirkegaard K. Improved method for detecting poliovirus negative strands used to demonstrate specificity of positive-strand encapsidation and the ratio of positive to negative strands in infected cells. J. Virol. 65:1991;3384-3387.
27. Palese P. The genes of influenza virus. Cell. 10:1977;1-10.
28. Pattnaik A. K., Ball L. A., LeGrone A. W., Wertz G. W. Infectious defective interfering particles of VSV from transcripts of a cDNA clone. Cell. 69:1992;1011-1020.
29. Pleschka S., Jaskunas R., Engelhardt O. G., Zurcher T., Palese P., Garcia-Sastre A. A plasmid-based reverse genetics system for influenza A virus. J. Virol. 70:1996;4188-4192.
30. Rey O., Nayak D. Nuclear retention of M1 protein in a temperature-sensitive mutant of influenza (A/WSN/33) virus does not affect nuclear export of viral ribonucleoproteins. J. Virol. 66:1992;5815-5824.
31. Ritchey M. B., Palese P. Identification of the defective genes in three mutant groups of influenza virus. J. Virol. 21:1977;1196-1204.
32. Sha B., Luo M. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat. Struct. Biol. 4:1997;239-244.
33. Shapiro G., Gurney T. Jr., Krug R. Influenza virus gene expression: Control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs. J. Virol. 61:1987;764-773.
34. Smith G. L., Levin J. Z., Palese P., Moss B. Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses [published erratum appears inVirology163, Virology. 160:1987;336-345.
35. Stemmer W. P., Morris S. K. Enzymatic inverse PCR: A restriction site independent, single-fragment method for high-efficiency, site-directed mutagenesis. BioTechniques. 13:1992;214-220.
36. Wakefield L., Brownlee G. RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Res. 17:1989;8569-8580.
37. Watanabe K., Handa H., Mizumoto K., Nagata K. Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. J. Virol. 70:1996;241-247.
38. Wharton S. A., Belshe R. B., Skehel J. J., Hay A. J. Role of virion M2 protein in influenza virus uncoating: Specific reduction in the rate of membrane fusion between virus and liposomes by amantadine. J. Gen. Virol. 75:1994;945-948.
39. Whittaker G., Kemler I., Helenius A. Hyperphosphorylation of mutant influenza virus matrix protein, M1, causes its retention in the nucleus. J. Virol. 69:1995;439-445.
40. Ye Z., Baylor N., Wagner R. Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J. Virol. 63:1989;3586-3594.
41. Ye Z., Robinson D., Wagner R. R. Nucleus-targeting domain of the matrix protein (M1) of influenza virus. J. Virol. 69:1995;1964-1970.
42. Zvonarjev A. Y., Ghendon Y. Z. Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine. J. Virol. 33:1980;583-586.